INS and metabolic dysfunction-associated steatotic liver disease: In fact, VLDL-TG secretion is less sensitive to insulin inhibition in NAFLD subjects (hepatic insulin resistance) [82], implying that the secretion of larger VLDL particles remains unabated during feeding cycles, thus contributing to dyslipidemia observed in NAFLD subjects.